Longevity startup Biopeak has secured US$2.7m in a follow-on funding round.
Founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak operates India’s first specialised brand aimed at extending lifespans through preventive care.
The company opened a clinic in Bengaluru last year and plans to open a second one in the coming month.
The funds will be used to expand Biopeak’s operations, including the new clinic and enhancements to its diagnostics, proprietary artificial intelligence tools, research initiatives and clinical programmes, Pardal said.
The startup also plans to hire talent for its clinical, research, product and operations teams while strengthening ties with global advisers for protocol development.
Pardal said: “Since our last fundraise, we conclusively proved we can attract clients and deliver outcomes.
“Around August, we started our second flagship store while building capabilities in new diagnostic tests and AI-driven diagnosis for personalised programmes.
“All this requires investment to further validate product-market fit and scale our systems.”
Biopeak targets high achievers, executives and women, relying on programmes mixing advanced diagnostics, specialist teams, wearable data and AI insights tailored to Indian biology and disease patterns.
The model stresses early risk detection, longitudinal tracking and interventions to improve performance and resilience.
The latest funding round was led by NKSquared, the investment vehicle of Zerodha co-founder Nikhil Kamath, marking his second investment in the company after he put US$1.43m into the health optimisation startup in August 2024.
Biopeak raised US$3m in seed funding in June from Claypond Capital, the family office of Manipal Group chairman Ranjan Pai, Accel India co-founder Prashanth Prakash and existing investor Rainmatter, the investment arm of Zerodha.
Over the past year, Biopeak has grown its client base and clinical offerings amid rising demand for structured longevity services.
Pardal said consumer attitudes towards proactive health are changing in India, but integrated systems linking diagnostics and follow-up remain scarce.
“Longevity and well-being interest is exploding across newspapers, social circles, and web searches; people have intent and awareness,” the chief executive added.
